Home
Welcure Drugs & Pharmaceuticals Ltd Board of Directors
Board of Directors at Welcure Drugs & Pharmaceuticals Ltd
Non-Exec. & Independent Dir.
Company Sec. & Compli. Officer
Independent Director
Additional Director
Additional Director
Key Highlights
- Pradeep Dnyaneshwar Terse joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Altaf Hussain Shah joins the board as Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ravi Thakor joins the board as Additional Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Yogeshkumar Prajapati joins the board as Additional Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Bhumika Pradhan joins the board as Additional Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Welcure Drugs & Pharmaceuticals Ltd
NSE: WELCUREDRUGS
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 24 Oct 2025 | 0.68 |
| 23 Oct 2025 | 0.71 |
| 21 Oct 2025 | 0.74 |
| 20 Oct 2025 | 0.77 |
| 17 Oct 2025 | 0.74 |
| 16 Oct 2025 | 0.77 |
| 15 Oct 2025 | 0.74 |
| 14 Oct 2025 | 0.77 |
| 13 Oct 2025 | 0.73 |
| 10 Oct 2025 | 0.7 |
Company Fundamentals for Welcure Drugs & Pharmaceuticals Ltd
Market Cap
84 Cr
EPS
0.2
P/E Ratio (TTM)
3.1
P/B Ratio (TTM)
0.8
Day’s High
0.68
Day’s Low
0.68
DTE
1.2
ROE
2.1
52 Week High
1.44
52 Week Low
0.48
ROCE
1.2
Market Price of Welcure Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Welcure Drugs & Pharmaceuticals Ltd News Hub
Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.35 crore in the June 2024 quarter
Net Loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.35 crore in the quarter ended June 2024
Read more
14 Aug 24
Welcure Drugs & Pharmaceuticals to table results
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 A
Read more
09 Aug 24
Welcure Drugs & Pharmaceuticals to hold board meeting
Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 Se
Read more
30 Aug 24
Welcure Drugs & Pharmaceuticals to conduct AGM
Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will
Read more
11 Sept 24
